Thanks, biopearl. I think the story in #msg-28748342 contributed to the big rise today. Not only does this accomplishment add credibility to MNTA’s characterization technology, but it also presumably puts MNTA on good terms with the FDA from MNTA’s having helped the Agency deal with a problem that had caused considerable political flak.
>I still like my idea about Genz. Is that shot glass still around? If its Genz can I have it?<
Absolutely, but you won’t be able to get it from me! All that stuff precedes my involvement with GTCB.
>Although Crou thinks the partnership will follow the general meeting, this seems unlikely to me.<
I’m with you—I think GTC will try very hard to assure that a deal is wrapped up in time for the annual meeting. Regards, Dew
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.